Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 20,000 shares at $8.14 ($163K) on 2021-09-14, disclosed to the SEC on 2021-09-15.
Open-market sale of $163k PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |